Latest News

APP Insights Into AD Therapy: Systemics May Improve Patient Compliance
APP Insights Into AD Therapy: Systemics May Improve Patient Compliance

November 8th 2024

APPs found that patients on systemic therapies for AD experience fewer issues with adherence compared to those using topicals only.

PDUFA Date for Tapinarof 1% Cream in Atopic Dermatitis Pushed to 2025
PDUFA Date for Tapinarof 1% Cream in Atopic Dermatitis Pushed to 2025

November 5th 2024

Off-Treatment Remission Achieved with Dupilumab for Pediatric AD
Off-Treatment Remission Achieved with Dupilumab for Pediatric AD

November 4th 2024

Rademikibart Differentiates From Dupilumab With Optimized IL-4Rα Inhibition and Enhanced Binding Stability
Rademikibart Differentiates From Dupilumab With Optimized IL-4Rα Inhibition and Enhanced Binding Stability

November 1st 2024

Effectiveness of Dupilumab on Special Sites in Atopic Dermatitis
Effectiveness of Dupilumab on Special Sites in Atopic Dermatitis

November 1st 2024

Latest CME Events & Activities

Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)

View More

Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia

View More

Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis

November 21, 2024 - December 5, 2024

View More

21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

February 8, 2025

View More

Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis

View More

Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making

View More

Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis

View More

Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color

View More

Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach

View More

Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis

View More

Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis

View More

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

View More

More News

© 2024 MJH Life Sciences

All rights reserved.